Arepanrix
split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.
Centralised EU authorisationWithdrawn
Marketing holder: GlaxoSmithKline Biologicals S.A.
Verified 2026-10-09 · EMA
- Source: EMA
Composition
- split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.
Registration
- Registration number
- EMEA/H/C/001201
- Registration status
- Withdrawn
- ATC code
- J07BB02
Sources
- product · EMA · EMEA/H/C/001201 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001201 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001201 · Verified 2026-10-09